| 1. |
中華醫學會腫瘤學分會, 中華醫學會雜志社. 中華醫學會肺癌臨床診療指南(2022版). 中華腫瘤雜志, 2022, 44(6): 457-490.
|
| 2. |
Kalhor N, Moran CA. Pulmonary mucoepidermoid carcinoma: diagnosis and treatment. Expert Rev Respir Med, 2018, 12(3): 249-255.
|
| 3. |
王英禹, 程慶書, 張瑞, 等. 氣管粘液腺癌、粘液表皮樣癌一例. 中國胸心血管外科臨床雜志, 2007, 14(5): 333.
|
| 4. |
黃文鵬, 李莉明, 王芳, 等. 結外鼻型NK/T細胞淋巴瘤合并支氣管黏液表皮樣癌及肺腺癌一例. 中華放射學雜志, 2021, 55(8): 875-876.
|
| 5. |
Ponea AM, Marak CP, Sun Y, et al. Unusual synchronous lung tumors: mucoepidermoid carcinoma and mucinous adenocarcinoma. Case Rep Oncol Med, 2014, 2014:183617.
|
| 6. |
Hsieh MS, Lee YH, Chen JS, et al. Mixed mucoepidermoid carcinoma and adenocarcinoma of the lung: Two cases with unusual histologic features. Lung Cancer, 2015, 89(1): 80-83.
|
| 7. |
Jhuang JY, Chou YH, Hua SF, et al. Mixed Lung Mucoepidermoid Carcinoma and Adenocarcinoma With Identical Mutations in an Epidermal Growth Factor Receptor Gene. Ann Thorac Surg, 2014, 98(2): 695-697.
|
| 8. |
劉燁, 田樹平, 聶永康, 等. 肺原發黏液表皮樣癌的影像表現與臨床病理分析. 中國醫學科學院學報, 2022, 44(3): 433-439.
|
| 9. |
莊武, 王文嫻, 林雪平, 等. 肺黏液表皮樣癌的分子特征. 臨床與病理雜志, 2017, 37(7): 1382-1386.
|
| 10. |
Roden AC. Recent updates in salivary gland tumors of the lung. Semin Diagn Pathol, 2021, 38(5): 98-108.
|
| 11. |
侯晶晶, 王慧娟, 張國偉, 等. 29例肺粘液表皮樣癌的臨床分析. 中國肺癌雜志, 2017, 20(3): 168-174.
|
| 12. |
Roden AC, Garcia JJ, Wehrs RN, et al. Histopathologic, immunophenotypic and cytogenetic features of pulmonary mucoepidermoid carcinoma. Mod Pathol, 2014, 27(11): 1479-1488.
|
| 13. |
張曉平, 胡培珠, 申淑景, 等. 87例肺黏液表皮樣癌患者的臨床病理特征和預后分析. 中華腫瘤雜志, 2018, 40(6): 452-455.
|
| 14. |
Huo Z, Wu H, Li J, et al. Primary Pulmonary Mucoepidermoid Carcinoma: Histopathological and Moleculargenetic Studies of 26 Cases. PLoS One, 2015, 10(11): e143169.
|
| 15. |
Kim NI, Lee JS. Greater specificity of p40 compared with p63 in distinguishing squamous cell carcinoma from adenocarcinoma in effusion cellblocks. Cytojournal, 2020, 17:13.
|
| 16. |
Sams RN, Gnepp DR. P63 expression can be used in differential diagnosis of salivary gland acinic cell and mucoepidermoid carcinomas. Head Neck Pathol, 2013, 7(1): 64-68.
|
| 17. |
Yan Y, Li X, Peng Y, et al. Apatinib and fractionated stereotactic radiotherapy for the treatment of limited brain metastases from primary lung mucoepidermoid carcinoma: A case report. Medicine (Baltimore), 2020, 99(43): e22925.
|
| 18. |
Salem A, Bell D, Sepesi B, et al. Clinicopathologic and genetic features of primary bronchopulmonary mucoepidermoid carcinoma: the MD Anderson Cancer Center experience and comprehensive review of the literature. Virchows Archiv, 2017, 470(6): 619-626.
|
| 19. |
張欣, 柏乾明, 姚茜嵐, 等. 原發性肺黏液表皮樣癌MAML2基因重排、融合形式及臨床病理學特征. 中華病理學雜志, 2021, 50(8): 891-898.
|
| 20. |
Taniuchi M, Kawata R, Terada T, et al. Management and outcome of parotid mucoepidermoid carcinoma by histological grade: A 21‐year review. Laryngoscope Investig Otolaryngol, 2022, 7(3): 766-773.
|
| 21. |
Yu Y, Song Z, Gao H,, et al. EGFR L861Q mutation is a frequent feature of pulmonary mucoepidermoid carcinoma. J Cancer Res Clin Oncol, 2012, 138(8): 1421-1425.
|
| 22. |
Meador CB, Piotrowska Z. Biology and impact of lineage plasticity in ALK-positive NSCLC: a narrative review. Transl Lung Cancer Res. 2023,12(4): 837-856.
|
| 23. |
Vogt A, Schmid S, Heinimann K, et al. Multiple primary tumours: challenges and approaches, a review. ESMO Open, 2017, 2(2): e172.
|
| 24. |
Xi JJ, Jiang W, Lu SH,, et al. Primary pulmonary mucoepidermoid carcinoma: an analysis of 21 cases. World J Surg Oncol, 2012, 10:232.
|
1/5
WeChat